Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Long-acting compound sulfametoxydiazine sodium injection for veterinary use and preparation method thereof

A technology for sodium sulfa-p-methoxy-pyrimidine and sodium methoxy-pyrimidine is applied in the field of veterinary long-acting compound sulfa-p-methoxy-pyrimidine sodium injection and preparation thereof, and can solve the problem of vitamin B1 deficiency, high irritation, and high liver and kidney toxicity. and other problems, to achieve the effect of reducing toxic side effects, reducing irritation, and saving costs

Active Publication Date: 2014-03-19
HUBEI WUDANG ANIMAL PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The compound sulfamethoxine sodium injection prepared according to the 2010 version quality standard of "Chinese Veterinary Pharmacopoeia" has two defects in clinical application: 1. The pH value of compound sulfamethoxine sodium is 10.0-11.0, which is an alkali After the alkaline injection is injected into the animal body, it is very irritating and often forms a local lump at the injection site
2. Sulfonamide drugs are highly toxic to the liver and kidney when administered in large quantities and for a long time. The imbalance of intestinal flora often causes vitamin B1 deficiency, resulting in side effects such as anorexia, leukopenia, and loss of appetite.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-acting compound sulfametoxydiazine sodium injection for veterinary use and preparation method thereof
  • Long-acting compound sulfametoxydiazine sodium injection for veterinary use and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] (1) Weigh 50g of glycerol methylal, 100g of α-pyrrolidone, and 200g of polyethylene glycol 400 (PEG400) into the batching tank, heat to 70-80°C, add 150g of polyvinylpyrrolidone while stirring, and then stir while stirring. Add trimethoprim 20g, continue to stir for 10-20 minutes to dissolve, for subsequent use;

[0033] (2) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80℃, add sulfonamide to

[0034] 10 g of sodium methoxine was stirred and dissolved, for use;

[0035] (3) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80℃, add 30g of taurine and 50g of vitamin B1, stir and dissolve, and set aside for later use;

[0036] (4) Add solution (2) and solution (3) to solution (1) in turn, stir evenly, and add 5 g of benzyl alcohol. Adjust the pH to 7.0-8.0 with 10g of sodium butyrate or 10g of arginine, and add water for injection to 1000ml;

[0037] (5) After filtration, fil...

Embodiment 2

[0039] (1) Weigh 100 g of glycerol methylal, 150 g of α-pyrrolidone, and 300 g of polyethylene glycol 400 (PEG400) into the batching tank, heat to 70-80 °C, add 200 g of polyvinylpyrrolidone while stirring, and then stir while stirring. Add trimethoprim 40g, continue to stir for 10-20 minutes to dissolve, for subsequent use;

[0040] (2) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80°C, add 20g of sulfamethoxine sodium and stir to dissolve, for later use;

[0041] (3) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80℃, add 50g of taurine and 100g of vitamin B1, stir and dissolve, and set aside for later use;

[0042] (4) Add solution (2) and solution (3) to solution (1) in turn, stir evenly, and add 10 g of benzyl alcohol. Adjust the pH to 7.0-8.0 with 20g of sodium butyrate or 20g of arginine, and add water for injection to 1000ml;

[0043] (5) After filtration, fill in ampoul...

Embodiment 3

[0045] (1) Weigh 80 g of glycerol methylal, 120 g of α-pyrrolidone, and 230 g of polyethylene glycol 400 (PEG400) into the batching tank, heat to 70-80 ° C, add 200 g of polyvinylpyrrolidone while stirring, and then stir Add trimethoprim 20g, continue to stir for 10-20 minutes to dissolve, for subsequent use;

[0046] (2) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80℃, add 10g of sulfamethoxine sodium, stir and dissolve, and set aside for later use;

[0047] (3) Weigh 10-20g of water for injection and put it into a stainless steel bucket and heat it to 60-80℃, add 40g of taurine and 70g of vitamin B1, stir and dissolve, and set aside for later use;

[0048] (4) Add solution (2) and solution (3) to solution (1) in turn, stir evenly, and add 7g of benzyl alcohol. Adjust the pH to 7.0-8.0 with 10g of sodium butyrate or 10g of arginine, and add water for injection to 1000ml;

[0049] (5) After filtration, fill in ampoules with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a long-acting compound sulfametoxydiazine sodium injection for veterinary use and a preparation method thereof. 1000ml of injection comprises the following components: 10-20g of sulfametoxydiazine, 20-40g of trimethoprim, 30-50g of taurine, 50-100g of vitamin B1, 50-100g of auxiliary material glycerinum methylal, 100-150g of alpha-pyrrolidone, 200-300g of polyethylene glycol 400 (PEG400), 150-200g of polyvinylpyrrolidone, 10-20g of sodium butyrate or 10-20g of arginine, 5-10g of benzyl alcohol, and the balance of water for injection use. According to the preparation method, the long-acting compound sulfametoxydiazine sodium injection for veterinary use is prepared by dissolving all the components into water for injection use. The long-acting compound sulfametoxydiazine sodium injection for veterinary use has the advantages of having controlled release and long-acting effects, being injected once every two days, saving manual work and cost, reducing stress increased by catching pigs and injecting, and being beneficial for ill pigs to recovery, lowering the toxic and side effects of sulfametoxydiazine in clinical application, and greatly lowering irritation to animals in injection due to the neutral pH value of the long-acting compound sulfametoxydiazine sodium injection.

Description

technical field [0001] The invention belongs to the field of veterinary drug preparations, in particular to a veterinary long-acting compound sulfamethoxine sodium injection and a preparation method thereof. Background technique [0002] Sulfamethoxine sodium belongs to sulfonamide drugs, broad-spectrum antibacterial, clinically mainly used to treat piglet edema caused by sensitive bacteria, pig atrophic rhinitis, actinobacillus pleuropneumonia, piglet yellow, pullorum, pig toxoplasmosis , porcine colibacillosis, etc., clinical application is very extensive, especially for the treatment of porcine toxoplasma has special effects. [0003] The compound sulfamethoxine sodium injection prepared according to the 2010 version quality standard of "Chinese Veterinary Pharmacopoeia" has two defects in clinical application: 1. The pH value of compound sulfamethoxine sodium is 10.0-11.0, which is an alkali In a sexual environment, after the alkaline injection is injected into the anim...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/635A61K9/08A61P31/04A61K31/505A61K31/185A61K31/51
Inventor 张伟才陈国明
Owner HUBEI WUDANG ANIMAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products